☆ 4.5 Letter

Venetoclax-ponatinib for T315I/compound-mutated Ph plus acute lymphoblastic leukemia

BLOOD CANCER JOURNAL (2022)

Get Full Text
Add to Collection

Journal

BLOOD CANCER JOURNAL
Volume 12, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41408-022-00621-9

Keywords

-

Categories

Oncology Hematology

Funding

  1. Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang [2020R01006, 2019R01001]
  2. National Natural Science Foundation of China [81820108004, 82170144, 81872942]
  3. Key Research and Development Program of Zhejiang [2021C03123]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.